{"disease":{"id":"indication-of-the-parent-protocol","name":"indication of the parent protocol"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07456891","title":"Remibrutinib Open Label Roll-over Post-trial Access Protocol","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":212,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}